Filing Details

Accession Number:
0001209191-17-022772
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-24 16:41:02
Reporting Period:
2017-03-22
Filing Date:
2017-03-24
Accepted Time:
2017-03-24 16:41:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
827871 Eagle Pharmaceuticals Inc. EGRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1599743 L. Steven Krill C/O Eagle Pharmaceuticals, Inc.
50 Tice Blvd., Suite 315
Woodcliff Lake NJ 07677
Evp & Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-22 5,023 $4.42 5,023 No 4 M Direct
Common Stock Acquisiton 2017-03-22 2,077 $12.67 7,100 No 4 M Direct
Common Stock Disposition 2017-03-22 7,100 $80.09 0 No 4 S Direct
Common Stock Acquisiton 2017-03-23 2,025 $12.67 2,025 No 4 M Direct
Common Stock Acquisiton 2017-03-23 5,000 $12.63 7,025 No 4 M Direct
Common Stock Disposition 2017-03-23 7,025 $82.06 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2017-03-22 5,023 $0.00 5,023 $4.42
Common Stock Employee Stock Option (right to buy) Disposition 2017-03-22 2,077 $0.00 2,077 $12.67
Common Stock Employee Stock Option (right to buy) Disposition 2017-03-23 2,025 $0.00 2,025 $12.67
Common Stock Employee Stock Option (right to buy) Disposition 2017-03-23 5,000 $0.00 5,000 $12.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
457 2023-04-18 No 4 M Direct
6,875 2024-04-07 No 4 M Direct
4,850 2024-04-07 No 4 M Direct
15,000 2024-08-25 No 4 M Direct
Footnotes
  1. 25% of the shares subject to the option vested on April 19, 2014 and the remainder shall vest in equal monthly installments over a period of three years.
  2. 25% of the shares subject to the option vested on April 8, 2015 and the remainder shall vest in equal monthly installments over a period of three years.
  3. 25% of the shares subject to the option vested on August 26, 2015 and the remainder shall vest in equal monthly installments over a period of three years.